Unlocking the Power of EMR Data for Earlier Gastric Cancer Diagnosis and Risk Prediction
By Léon Van Wouwe, Clinical Innovation Director, Volv Global Gastric (stomach) cancer remains a formidable global health challenge, ranking
By Léon Van Wouwe, Clinical Innovation Director, Volv Global Gastric (stomach) cancer remains a formidable global health challenge, ranking
ÉPALINGES, Switzerland, March 5, 2025 /PRNewswire-PRWeb/ Volv Global has more than doubled its office space for the fourth year
On the occasion of international Rare Disease Day 2025, we are beyond thrilled to host the voice of patient advocate
Volv Global sits at the crucial intersection between technology and human beings, i.e., patients and physicians, supporting favourable patient journeys
This article is also available in French and originally published 24 Heures. Read the original article Based in Épalinges, the small
By Volv Global SA and WODC EU contributors Executive Summary For decades, the pharmaceutical industry has faced the same
Ready to shape the future of healthcare? Let’s explore how our machine learning solutions can accelerate diagnoses, refine patient journeys, and drive meaningful impact for those who need it most. We value your ideas and expertise, reach out now to unlock new possibilities together.
